GlassScriptPhysician profile
Betsy J Beach
NPI 1457509598
$2,649.33
in general payments reported to CMS, 2019-2025
27 companies · $874 in 2025
The $874 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $275 · 2023: $628 · 2024: $716 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,137.19 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $459.29 | 2021-2025 | |
| Boston Scientific Corporation | $294.39 | 2021-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $280.95 | 2021-2025 | Farxiga, Brilinta, Wainua |
| Amgen INC. | $224.68 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $174.81 | 2021-2024 | Xarelto |
| Atricure, INC. | $142.57 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Esperion Therapeutics, INC. | $119.68 | 2023-2025 | Nexletol |
| Edwards Lifesciences Corporation | $117.69 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Novo Nordisk INC | $116.96 | 2023-2025 | Wegovy, Ozempic |
| Pfizer INC. | $108.34 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $99.72 | 2021-2023 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Abiomed | $66.66 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.52 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $52.56 | 2022-2025 | Uptravi, Opsumit |
| Kestra Medical Technology Services, INC. | $49.94 | 2025 | Assure Wcd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $46.97 | 2024 | Mitraclip |
| Kiniksa Pharmaceuticals International, Plc | $34.80 | 2024 | Arcalyst |
| Medtronic, INC. | $34.41 | 2022-2025 | Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $34.23 | 2024 | Eliquis, Camzyos |
| Cosa Medical, LLC | $23.60 | 2025 | |
| Amarin Pharma, INC. | $17.63 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.33 | 2022 | |
| Silk Road Medical, INC. | $16.82 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| American Regent | $16.19 | 2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.19 | 2024 | Jardiance |
| Daiichi Sankyo INC. | $14.80 | 2024 | Injectafer |
| Glaxosmithkline, LLC. | $14.60 | 2025 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Beach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.